Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Newer Targets
Stanford researchers program cancer-fighting cells to resist exhaustion, attack solid tumors…
Newer Targets
Dyno Therapeutics Announces Research Published in Science Enabling Artificial Intelligence Approach…
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
FDA Committee Votes 6-6 on Durect’s Non-Opioid Pain Drug
Approval
Novo Nordisk’s Ozempic Wins Approval for Reducing Cardiovascular Events in Diabetes…
Clinical
FDA advisory panel split on whether to approve Durect’s Posimir for…
Approval
Breast cancer patients to have further NICE-approved drug combination option on…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Seneca Biopharma Surges Near 113% After Comments on Seeking Partnership for…
Deals
TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy…
Financial
US judge hacks $8-billion damages verdict against Johnson & Johnson in…
Deals
JPM Day 3: High Prices in San Francisco Are a Problem,…
Home
Commercial
Financial
Financial
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Financial
US judge hacks $8-billion damages verdict against Johnson & Johnson in Risperdal case down to $6.8 million
Firstwordpharma News
-
January 17, 2020
Financial
BioMarin eyes $2-million to $3-million price for experimental haemophilia A gene therapy Valrox
Financial
Emendo Biotherapeutics Raises $61 Million to Advance Next Generation Genome Editing Therapeutics
Financial
TAXIS Pharmaceuticals Announces CARB-X Award of $3.2 Million, With Potential for an Additional $11.4 Million, to Develop Efflux Pump Inhibitors (EPIs), a New Drug...
Financial
Codagenix Raises $20 Million in Series B Funding for Continued Development of RSV, Influenza and Oncolytic Virus Products
Financial
Tyra Biosciences Raises $50 Million to Focus on Cancer Drug Resistance
Biospace News
-
January 13, 2020
0
Financial
Tyra Biosciences raises $50M to develop therapies targeting acquired resistance in...
Firstwordpharma News
-
January 10, 2020
0
Financial
Matinas BioPharma Announces Pricing of Public Offering of Common Stock at...
Biospace News
-
January 10, 2020
0
Financial
Generation Bio Announces $110 Million Series C Financing to Advance Lead...
Firstwordpharma News
-
January 10, 2020
0
Financial
PACT Pharma Raises $75M in Oversubscribed Series C Financing to Develop...
Firstwordpharma News
-
January 10, 2020
0
1
2
3
...
109
Page 1 of 109
- Advertisement -
MOST POPULAR
Gilead and Galapagos to Present Latest Data on Filgotinib at the...
May 29, 2019
U.S. FDA Approves IBRANCE (palbociclib) for the Treatment of Men with...
April 4, 2019
iTeos Therapeutics Announces Collaboration with Merck Investigating the Combination of its...
December 12, 2019
RogCon Announces Presentation at World Orphan Drug Congress 2019
April 4, 2019
Load more
HOT NEWS
Immuno-oncology
Biomica Initiates Pre-clinical Studies in Its Immuno-oncology Program
Gastroenterology
Tesamorelin Study Results on NAFLD Published in Lancet HIV
Others
BioForest Hotbed: The Fastest-Growing Life Science Market
Commercial
CRISPR Therapeutics Announces Oral Presentation at the 55th Annual Meeting of...
